Revvity

In News

Revvity, Lilly Partner To Expand Access To AI Drug Discovery Models - Nasdaq

Nasdaq - Jan 09, 2026

Eli Lilly in pact with Schrödinger, Revvity for AI-driven drug discovery - MSN

MSN - Jan 09, 2026

Revvity (NYSE:RVTY) earnings and shareholder returns have been trending downwards for the last five years, but the stock lifts 5.1% this past week - simplywall.st

simplywall.st - Jan 09, 2026

Key facts: Eli Lilly to acquire Ventyx for $1.2B; Mounjaro pricing in India; AI partnership with Revvity - TradingView — Track All Markets

TradingView — Track All Markets - Jan 09, 2026

Revvity, Inc. Collaborates with Eli Lilly and Company to Expand Access to Ai Drug Discovery Models - MarketScreener

MarketScreener - Jan 09, 2026

Revvity Collaborates with Lilly to Expand Access to AI Drug Discovery Models - PharmiWeb.com

PharmiWeb.com - Jan 09, 2026

Revvity announces collaboration with Eli Lilly on AI drug discovery models - TipRanks

TipRanks - Jan 09, 2026

Revvity to Present at J.P. Morgan Healthcare Conference - Yahoo Finance

Yahoo Finance - Dec 18, 2025

What to Expect From Revvity’s Q4 2025 Earnings Report - Barchart.com

Barchart.com - Jan 05, 2026

Revvity introduces Signals Xynthetica, an AI-augmented design platform for molecular and materials discovery - Scientific Computing World

Scientific Computing World - Jan 06, 2026

Revvity collaborates with Lilly to expand access to AI drug discovery models - MarketScreener

MarketScreener - Jan 09, 2026

Q3 Earnings Highlights: Revvity (NYSE:RVTY) Vs The Rest Of The Research Tools & Consumables Stocks - Yahoo Finance

Yahoo Finance - Dec 22, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment